GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » 3-Year EBITDA Growth Rate

Genetic Signatures (ASX:GSS) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures 3-Year EBITDA Growth Rate?

Genetic Signatures's EBITDA per Share for the six months ended in Dec. 2024 was A$-0.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genetic Signatures was 31.50% per year. The lowest was -111.40% per year. And the median was 13.50% per year.

Competitive Comparison of Genetic Signatures's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Genetic Signatures's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's 3-Year EBITDA Growth Rate falls into.


;
;

Genetic Signatures 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Genetic Signatures  (ASX:GSS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Genetic Signatures 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » 3-Year EBITDA Growth Rate
Comparable Companies
ASX:IIQ ASX:MAP ASX:CTE ASX:BDX ASX:RHY ASX:IBX ASX:MVF TSE:2397 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA LH WAT DGX
Traded in Other Exchanges
N/A
Address
7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Website
https://www.geneticsignatures.com
Genetic Signatures Ltd is a specialist molecular diagnostics company, specialising in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are primarily based in Australia, with sales and support teams in the UK, Germany, and the United States.